Vinay Prasad was reinstated as the head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug ...

Chardan raised the firm’s price target on Taysha Gene Therapies (TSHA) to $10 from $9 and keeps a Buy rating on the shares. The company reported ...

A reusable product can help save money over the long term. Celikoyar estimates that she was using three tampons every day for ...

NewsNation's Robert Sherman reports that, in exchange for a ceasefire, Ukraine would have withdraw its troops from the Donbas region of eastern Ukraine – at least to some extent. In any capacity, this ...

A Food and Drug Administration official is getting his job back as the agency’s top vaccine regulator, less than two weeks ...

In our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or the Agency) that may affect ...

CDC shooting tied to anti-vaccine beliefs sparks warnings from staff, as leaders clash over the future of mRNA vaccines and ...

Artificial intelligence programs can help doctors and nurses predict hours earlier which ER patients will likely require ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

BACK TO CBER — Dr. Vinay Prasad has returned to the FDA’s Center for Biologics Evaluation and Research, leaving industry and ...

Regularly blowing through a conch shell for six months significantly improved sleep among a small group of people with sleep ...